| Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Net income | 47 | 34 | 43 | 38 | 42 | 86 | 119 | 100 | 23 | 47 | 64 | 7 |
---|
Depreciation, Depletion and Amortization | 18 | 27 | 37 | 39 | 39 | 33 | 39 | 49 | 58 | 57 | 57 | 59 |
---|
Amortization of intangible assets | - | - | - | 23 | 23 | 31 | 33 | 33 | 28 | 28 | 24 | 24 |
---|
Accounts Receivable, Credit Loss Expense (Reversal) | 62 | 47 | 38 | 63 | - | 77 | 80 | 86 | 8 | 20 | 14 | 25 |
---|
Provision for loans | - | - | - | - | - | - | - | - | - | - | 32 | - |
---|
Provision for loan losses | - | - | - | - | - | - | - | - | - | - | - | 26 |
---|
Stock-based compensation | 13 | 15 | 20 | 27 | 28 | 41 | 50 | 30 | 54 | 51 | 35 | 34 |
---|
Losses (earnings) in equity method investments | - | - | - | - | - | - | - | - | -6 | 2 | -16 | -9 |
---|
Realized gain on sale of available-for-sale investment securities | - | - | - | - | - | - | - | - | 5 | - | - | - |
---|
Amortization of Debt Discount (Premium) | 1 | 1 | 1 | 1 | 1 | 2 | 1 | -0 | 1 | 3 | -1 | -2 |
---|
Amortization of Debt Discount (Premium) | 1 | 1 | 1 | 1 | 1 | 2 | 1 | -0 | 1 | 3 | -1 | -2 |
---|
Impairment of long-lived assets | 1 | 5 | - | 6 | 0 | 1 | 1 | 1 | 22 | - | 4 | - |
---|
Impairment of long-lived assets | 1 | 5 | - | 6 | 0 | 1 | 1 | 1 | 22 | - | 4 | - |
---|
Deferred income tax (benefit) expense | 6 | 5 | 0 | -0 | 1 | 3 | -0 | 7 | -15 | 3 | -7 | -12 |
---|
Deferred income tax (benefit) expense | 6 | 5 | 0 | -0 | 1 | 3 | -0 | 7 | -15 | 3 | -7 | -12 |
---|
Other | - | - | - | - | - | - | - | - | - | -0 | 5 | 4 |
---|
Other | - | - | - | - | - | - | - | - | - | -0 | 5 | 4 |
---|
Accounts receivable, net | 66 | 48 | 30 | 54 | 75 | 68 | 85 | 105 | 16 | 32 | 8 | 60 |
---|
Prepaid expenses and other assets | 21 | -5 | -1 | 6 | -1 | 17 | 10 | 12 | -1 | 14 | -5 | -3 |
---|
Deferred expenses | -0 | 3 | 2 | -3 | 2 | 2 | -1 | -4 | 1 | -1 | -2 | -13 |
---|
Accounts payable and other accrued liabilities | 31 | 27 | 1 | 13 | -19 | 28 | 12 | -8 | 38 | -5 | 41 | 1 |
---|
Deferred revenue | - | - | - | - | - | - | 5 | -7 | 1 | 1 | -4 | -20 |
---|
Income tax receivable/payable | -1 | -3 | 4 | 10 | -7 | 5 | -1 | 12 | 10 | -14 | 12 | -6 |
---|
Other, net | - | - | - | - | - | -2 | -3 | -1 | 2 | 7 | 4 | -1 |
---|
Accounts receivable, net | 66 | 48 | 30 | 54 | 75 | 68 | 85 | 105 | 16 | 32 | 8 | 60 |
---|
Prepaid expenses and other assets | 21 | -5 | -1 | 6 | -1 | 17 | 10 | 12 | -1 | 14 | -5 | -3 |
---|
Deferred expenses | -0 | 3 | 2 | -3 | 2 | 2 | -1 | -4 | 1 | -1 | -2 | -13 |
---|
Accounts payable and other accrued liabilities | 31 | 27 | 1 | 13 | -19 | 28 | 12 | -8 | 38 | -5 | 41 | 1 |
---|
Deferred revenue | - | - | - | - | - | - | 5 | -7 | 1 | 1 | -4 | -20 |
---|
Income tax receivable/payable | -1 | -3 | 4 | 10 | -7 | 5 | -1 | 12 | 10 | -14 | 12 | -6 |
---|
Other, net | - | - | - | - | - | -2 | -3 | -1 | 2 | 7 | 4 | -1 |
---|
Net cash provided by operating activities | 102 | 123 | 69 | 157 | 112 | 218 | 251 | 190 | 209 | 163 | 278 | 98 |
---|
Purchases of available-for-sale investment securities | 272 | 274 | 212 | 195 | 136 | 59 | 187 | 189 | 994 | 1,396 | 932 | - |
---|
Proceeds from maturities of available-for-sale securities | 38 | 173 | 153 | 84 | 106 | 71 | 60 | 111 | 108 | 197 | 294 | 177 |
---|
Proceeds from Sale of Debt Securities, Available-for-Sale | 81 | 85 | 136 | 48 | 1 | 40 | 78 | 5 | 199 | 7 | 3 | 0 |
---|
Payments for property, equipment and internal-use software | 40 | 36 | 39 | 48 | 43 | 44 | 61 | 78 | 59 | 57 | 84 | 76 |
---|
Net changes in loans | -2 | -1 | -0 | -0 | -0 | 13 | 6 | 2 | 0 | 28 | 32 | 29 |
---|
Investment in TailFin Labs, LLC | - | - | - | - | - | - | - | - | 35 | 35 | 35 | 35 |
---|
Purchases of other investments | - | - | - | - | - | - | - | - | - | 55 | 32 | - |
---|
Other investing activities | - | - | - | - | - | - | - | - | - | 1 | 3 | 4 |
---|
Net cash provided by (used in) investing activities | -210 | -53 | -187 | -176 | -78 | -224 | -115 | -154 | -786 | -1,368 | -820 | 33 |
---|
Borrowings on revolving line of credit | - | - | 150 | 30 | 145 | 335 | - | 35 | 100 | - | 100 | 282 |
---|
Repayments on revolving line of credit | - | - | - | 30 | 145 | 335 | - | - | 135 | - | 65 | 256 |
---|
Proceeds from exercise of options and ESPP purchases | 4 | 14 | 7 | 4 | 15 | 24 | 22 | 7 | 17 | 8 | 6 | 6 |
---|
Taxes paid related to net share settlement of equity awards | - | - | - | 5 | 8 | 18 | 46 | 21 | 12 | 13 | 6 | 4 |
---|
Net changes in deposits | 159 | 21 | 346 | 87 | 85 | 285 | -17 | 146 | 1,554 | 555 | 157 | -159 |
---|
Net changes in settlement assets and obligations to customers | - | - | - | - | - | - | - | - | - | - | 54 | 132 |
---|
Contingent consideration payments | - | - | - | 1 | 3 | 3 | 5 | 5 | 4 | 4 | 2 | - |
---|
Repurchase of Class A common stock | - | - | - | 41 | 59 | 52 | - | 100 | - | - | 96 | - |
---|
Other financing activities | - | - | - | - | - | - | - | - | - | - | -4 | - |
---|
Net cash (used in) provided by financing activities | 179 | 58 | 419 | 66 | -73 | 192 | -51 | -65 | 1,007 | 1,035 | 37 | -264 |
---|
Net decrease in unrestricted cash, cash equivalents and restricted cash | - | - | - | - | - | - | - | -29 | 431 | -171 | -506 | -133 |
---|
Cash paid for interest | - | - | - | - | - | - | 5 | 2 | 1 | 1 | 1 | 6 |
---|
Income Taxes Paid, Net | - | - | - | - | - | - | 6 | 2 | 11 | 27 | 13 | 24 |
---|